DUBLIN–(BUSINESS WIRE)–The “PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to Include Impact of COVID-19 Diagnostics 2021 to 2025” report has been added to ResearchAndMarkets.com’s offering.
The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics.
COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?
Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician’s Office or even the Home? Will digital PCR become the new lab standard?
New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.
Key Topics Covered:
Market Guides
1. Introduction and Market Definition
1.1 What are PCR Technologies?
1.2 PCR and Syndromic Testing
1.3 Market Definition
1.4 Methodology
1.5 U.S. Medical Market and laboratory Testing – Perspective
2. PCR – Guide to PCR Technologies
2.1 Concepts
2.1.1 Method
2.2 Applications
2.2.1 Finding Specific DNA
2.2.2 Measuring DNA
2.2.3 Medical and diagnostic applications
2.3 PCR – Advantages and Disadvantages
2.4 Different Types of PCR
2.4.1 Simple Changes
2.4.2 Digital PCR
2.4.2.1 Droplet Digital PCR
2.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
2.4.2.3 Digital PCR in Use
2.4.2.4 Digital PCR Commercial History
2.4.3 Isothermal PCR
3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Genomic Instrumentation Supplier
3.1.4 Pharmaceutical/Reagent Supplier
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body
4. Market Trends
4.1 Factors Driving Growth
4.1.1 A New Standard
4.1.2 Down the Curve We Go
4.1.3 Multiplexing
4.1.4 Syndromic Diagnostics Looks Unstoppable
4.1.5 The Genetic Blizzard
4.2 Factors Limiting Growth
4.2.1 The Cost Curve
4.2.2 The Other Guys
4.2.3 Systemic Roadblocks
4.3 Diagnostic Technology Development
4.3.1 The Instrumentation Curve
4.3.2 Shifting Role of Diagnostics
4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
4.3.5 The Next Five Years
5. PCR Recent Developments
5.1 Recent Developments – Importance and How to Use This Section
5.1.1 Importance of These Developments
- Scope Fluidics Secures €6.2M Supporting Rapid MDx
- Quidel Expects SARS-CoV-2 Testing Demand to Continue ‘Through 2022, and Beyond’
- Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
- Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
- Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
- HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
- Israel’s Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
- Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
- DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
- Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
- ChromaCode Raises $28M based on new High Definition PCR Technology
- ddPCR Used for Fast and Low-Cost NIPT Screening
- Study Validates ChromaCode HDPCRT Testing for Tick-Borne Pathogens
- Bio-Rad’s ddPCR MSI RUO Assay is available
- ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
- Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
- QIAGEN Plans for Next-Generation Digital PCR Systems
- Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
- New PCR Technology: Transfer-PCR (tPCR) Applications
- NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
- Natera Applies Massively Multiplexed PCR to Kidney Transplants
- Paragon Genomics, MGI Tech Form Distribution Alliance
- Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
- Qiagen, NeuMoDx Ink Partnership, Merger Agreement
- Bruker to Acquire Majority in Hain Lifescience GmbH
- Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
- Cancer Early Detection Firm Ark Launches With $40M Series A Investment
- PredictImmune Wins £100K Grant for Study of IBD Prognostic
- Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
- llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
- Bio-Rad Wins USDA Food Safety Testing Contract
- Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal
6. Profiles of Key PCR Companies
- Abbott Diagnostics (Alere)
- Accelerate Diagnostics
- Agilent
- Alveo Technologies
- Applied BioCode
- Atlas Genetics
- Aus Diagnostics
- BD Diagnostics
- Biocartis
- BioFire Diagnostics
- bioMerieux
- Bioneer
- Bio-Rad Laboratories
- Bosch Healthcare Solutions GmbH
- Bruker
- Cepheid
- Curetis
- Diagenode Diagnostics
- Diasorin
- Fluidigm
- Fusion Genomics
- GenePOC Diagnostics
- GenMark Dx
- Hologic
- Invetech
- Janssen Diagnostics
- Karius
- Lexigene
- Luminex
- Mesa Biotech
- Mobidiag
- Nanomix
- Panagene
- Precipio
- Primerdesign
- Prominex
- Qiagen (Statdx)
- Quantumdx
- Roche Molecular Diagnostics
- Seegene
- Stilla Technologies
- Siemens Healthineers (Fast Track Diagnostics)
- SkylineDx
- T2 Biosystems
- Thermo Fisher
- Veramarx
- XCR Diagnostics
7. The PCR Markets
8. Global PCR Markets – By Application
8.1 Global Market by Application – Overview
8.2 PCR Clinical Multiplex
8.3 PCR Clinical Singleplex
8.4 PCR Research
8.5 PCR Single C19
9. Global PCR Markets – By Technology
9.1 Global Market by Technology – Overview
9.2 qPCR
9.3 dPCR
9.4 Single C19 PCR
For more information about this report visit https://www.researchandmarkets.com/r/1q7s9w
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
